Growth during infancy and early childhood in children with cerebral palsy: a population‐based study

Kristin Melheim Strand , Magnus O Dahlseng , Stian Lydersen , Torstein B Rø
Developmental Medicine & Child Neurology 58 ( 9) 924 -930

12
2016
Rehabilitation of executive function in chronic paediatric brain injury: a randomized controlled trial

Anne E Brandt , Torun G Finnanger , Ruth E Hypher , Torstein B Rø
BMC medicine 19 1 -15

16
2021
Assessment of executive function in everyday life—Psychometric properties of the norwegian adaptation of the children’s cooking task

Torun G Finnanger , Stein Andersson , Mathilde Chevignard , Gøril O Johansen
Frontiers in human neuroscience 15 761755 -761755

12
2022
Cognitive rehabilitation in paediatric acquired brain injury—A 2-year follow-up of a randomised controlled trial

Hanna L Sargénius , Stein Andersson , Ingvild Haugen , Ruth Hypher
Frontiers in Neurology 14 1173480 -1173480

3
2023
Predictors of functional school outcome in children with pediatric acquired brain injury

Jan Stubberud , Ruth Hypher , Anne E Brandt , Torun G Finnanger
Frontiers in neurology 13 872469 -872469

2
2022
Intelligence and executive function are associated with age at insult, time post-insult, and disability following chronic pediatric acquired brain injury

Anne Elisabeth Brandt , Torstein B Rø , Torun G Finnanger , Ruth E Hypher
Frontiers in Neurology 14 1192623 -1192623

1
2024
Prevalence and associations of impaired awareness of hypoglycemia in a pediatric type 1 diabetes population–The Norwegian Childhood Diabetes Registry

Håvard Hatle , Torild Skrivarhaug , Marit R Bjørgaas , Bjørn O Åsvold
Diabetes Research and Clinical Practice 209 111093 -111093

1
2024
Anti-c-Met Nanobody®: A potential new drug in cancer treatment.

Tobias S Slørdahl , Tinneke Denayer , Siv Helen Moen , Therese Standal
Cancer Research 73 ( 8_Supplement) 5624 -5624

2013
Conflict of interest: The authors declare no conflict of interest

Pegah Abdollahi , Esten N Vandsemb , Magnus A Hjort , Kristine Misund

Reduced Th22 cell proportion and prevention of atopic dermatitis in infants following maternal probiotic supplementation

A. D. B. Rø , M. R. Simpson , T. B. Rø , O. Storrø
Clinical & Experimental Allergy 47 ( 8) 1014 -1021

27
2017
Interleukin-21 is a growth and survival factor for human myeloma cells.

Torstein B Ro , AT Brenne , A Waage , A Sundan
Blood 98 ( 11) 773A -773A

4
2001
2015
Functional aspects of decreased bone marrow plasma concentrations of decorin in patients with MGUS and multiple myeloma

Henrik Jørn Ditzel , Magne Børset , Niels Abildgaard , Maria Bibi Lyng
XIVth International Myeloma Workshop

2013
Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.

Tobias Schmidt Slørdahl , Tinneke Denayer , Siv Helen Moen , Therese Standal
European Journal of Haematology 91 ( 5) 399 -410

53
2013
PRL-3 Mediates Survival of Primary Myeloma Cells

Torstein Baade Rø , Tobias Schmidt Slordahl , Pegah Abdollahi , Esten Vansemb
Blood 124 ( 21) 2040 -2040

2014
Health-related quality of life in adolescents with CFS/ME, a cross-sectional population based Norwegian study.

Wenche Ann Similä , Vidar Halsteinli , Ingrid B. Helland , Christer Suvatne

2020
Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration

Esten N. Vandsemb , Helena Bertilsson , Pegah Abdollahi , Øystein Størkersen
Journal of Translational Medicine 14 ( 1) 71 -71

16
2016